Emad Dodin, MD
Interventional Cardiology · Eau Claire, WINPI 1295929255
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,499 of the $4,946 with a category attached, or 70.7%. Medtronic accounts for 74.0% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $2,995 and has fallen 59.3% since, to $1,220 in 2025.
Across 64 payments — averaging $77.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Abiomed$525
- Abbott$270
- Novartis$117
- Boston Scientific$67
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$56
- plus $253 from 9 others
What the payments were for
- Travel & lodging$3,49971%
- Food & beverage$1,44729%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 27 | $3,658 |
| Abiomed | 2 | $525 |
| Abbott | 9 | $270 |
| Novartis | 8 | $117 |
| Boston Scientific | 3 | $67 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $56 |
| Baxter Healthcare | 2 | $46 |
| Pfizer | 3 | $45 |
| Inari Medical, Inc. | 1 | $41 |
| Cvrx, Inc. | 1 | $34 |
| Inspire Medical Systems, Inc. | 1 | $31 |
| Novo Nordisk | 1 | $20 |
| Impulse Dynamics (USA) Inc. | 1 | $16 |
| Smith+Nephew | 1 | $12 |
| Cardiovascular Systems Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,946 in reported general payments places this provider in the 55th percentile of 118 interventional cardiology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 188 | $179,722 |
| XareltoRivaroxaban | 24 | $31,103 |
| EntrestoSacubitril/Valsartan | 24 | $26,939 |
| Metoprolol Succinate | 335 | $3,515 |
| Ezetimibe | 193 | $3,113 |
| Rosuvastatin Calcium | 191 | $1,969 |
| Atorvastatin Calcium | 158 | $1,418 |
| Midodrine Hcl | 14 | $1,417 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 56 | $1,208 |
| Nebivolol Hcl | 15 | $1,158 |
| Losartan Potassium | 121 | $1,138 |
| Prasugrel Hcl | 14 | $1,111 |
| Amiodarone Hcl | 25 | $954 |
| Spironolactone-HctzSpironolact/Hydrochlorothiazid | 26 | $854 |
| Digoxin | 28 | $793 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $45 | $179,722188 claims |
| NovartisEntresto | $117 | $26,93924 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 118 interventional cardiology providers in Wisconsin.
Other interventional cardiology in Eau Claire
- Peter KlugeEau Claire$5K
- Michael SalingerMilwaukee$216K
- Arun KalyanasundaramMarshfield$201K
- Michael RosenbergManitowoc$111K
- Tanvir BajwaMilwaukee$106K
- Suhail AllaqabandMilwaukee$88K
- Saif AnwaruddinMilwaukee$80K
- Raaid MuseitifKenosha$71K
- Iyad AzzamMilwaukee$60K
- Mark HoffmannWausau$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.